August 27, 2016 10:59 PM ET

Pharmaceuticals

Company Overview of Pacira Pharmaceuticals, Inc.

Executive Profile

Laura A. Brege

Independent Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee, Pacira Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 11 different industries.

See Board Relationships
58$395,978

Background

Ms. Laura A. Brege served as the Chief Executive Officer and President of Nodality, Inc., from September 24, 2012 to July 2015. Ms. Brege has more than five decades of biotechnology and pharmaceutical industry experience with both privately-held and publicly-traded companies. Prior to joining Nodality in 2012, she served as an Executive Vice President of Corporate Affairs at Onyx Pharmaceuticals, Inc from January 2011 to December 31, 2011 and served as its Executive ...

Corporate Headquarters

5 Sylvan Way
Parsippany, New Jersey 07054

United States

Phone: 973-254-3560
Fax: --

Board Members Memberships

Director
Director
2008-Present
Independent Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee
2011-Present
Independent Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee
2014-Present
Director and Chairman of Audit Committee
2015-Present
Director and Chairman of Audit Committee
2015-Present
Independent Director and Member of Audit Committee

Education

MBA
The University of Chicago
BA
Ohio University
BS
Ohio University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

Exercisable Options$27,000
Unexercisable Options$4,000
Total Number of Options$31,000

Total Compensation

Total Annual Cash Compensation$79,227
Total Calculated Compensation$395,978
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
$477.4K
Lars Marcher Chief Executive Officer, President and Member of Executive Board
Ambu A/S
--
A. J. Kazimi MBAFounder, Chairman, Chief Executive Officer and President
Cumberland Pharmaceuticals, Inc.
$720.0K
Leon O. Moulder Jr., M.B.A.Co-Founder, Chief Executive Officer and Director
Tesaro, Inc.
$618.1K
Robert E. Abernathy Chairman, Chief Executive Officer, President and Member of Executive Committee
Halyard Health, Inc.
$837.4K
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Pacira Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.